FDA CLEARS R2 DIGITALNOW HD SOFTWARE APPLICATION.

Hologic, Inc. (NASDAQ:HOLX), Bedford, Mass., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, has received Food and Drug Administration (FDA) clearance for its R2(TM) DigitalNow(TM) HD software application.

The R2 DigitalNow HD software is the only FDA-cleared application intended to process digitized screen-film mammograms for comparison purposes. The product is now available worldwide.

By collaborating with radiologists to understand the demands of reading digital mammograms, Hologic created the R2 DigitalNow HD software, which adapts each digitized film image to a selected contrast and tissue intensity that models a digital mammography system. It also embeds a series of look-up tables in the image that allow Integrated Healthcare Enterprise (IHE) mammography conformant workstations to draw out less evident regions of density within digitized films.(1)

"The DigitalNow HD software is designed to enhance workflow by promoting consistency in the digital mammography reading environment," said Julian Marshall, director, R2 product management & principal engineer at Hologic. "One of the most powerful capabilities of this product is that images already digitized by R2 DigitalNow software and stored in PACS can be routed to R2 DigitalNow HD and reprocessed."

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

(1) The "IHE Mammo" profile defines the necessary mammography requirements for the display quality, behavior, layout and annotation of prior and current mammography image for diagnostic workstations.

For more information, http://www.hologic.com or call 781/999-7583.

Print Get the Mag Weekly Updates